We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aurobindo Pharma said it’s wholly-owned subsidiary has entered into an agreement to acquire a product under development and related assets from Australia-based
Ms. Olivia Lam, Executive Director at Cedrus Investments ("Cedrus"), was one of the three keynote speakers at the "Australia Biotech Invest" held in Melbourne on 24th October 2017.